Harmony Biosciences Holdings (HRMY) — Free Cash Flow Generation Index
Harmony Biosciences Holdings (HRMY) has a Free Cash Flow Generation Index of 1.00x as of September 2025. Free cash flow of $108.66 Million represents 1% of operating cash flow ($108.73 Million). See HRMY net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Harmony Biosciences Holdings Free Cash Flow Generation Index (2021–2024)
Historical FCF Generation Index trend for Harmony Biosciences Holdings across 4 annual periods. Explore Harmony Biosciences Holdings cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Harmony Biosciences Holdings (2021–2024)
Year-by-year Free Cash Flow Generation Index for Harmony Biosciences Holdings. For the full company profile including market capitalisation, see HRMY stock market capitalisation.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.99x | $218.67 Million | $219.82 Million | $1.15 Million | ▼ -0.4% |
| 2023 | 1.00x | $219.07 Million | $219.39 Million | $312.00K | ▼ 0.0% |
| 2022 | 1.00x | $144.29 Million | $144.47 Million | $172.00K | ▲ +0.2% |
| 2021 | 1.00x | $98.26 Million | $98.56 Million | $298.00K | — |